WALPARPharmaceuticals
WALPAR NUTRITIONS — Profit & Loss Statement
₹45.50
+0.00%
WALPAR NUTRITIONS Profit & Loss Statement (Annual)
| Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
| Tax Effect Of Unusual Items | 0.01 Cr | -0.02 Cr | -45600.00 | -407.23 |
| Tax Rate For Calcs | 0.22 | 0.27 | 0.30 | 0.08 |
| Normalized EBITDA | 4.87 Cr | 3.85 Cr | 1.06 Cr | 0.46 Cr |
| Total Unusual Items | 0.06 Cr | -0.07 Cr | -0.02 Cr | -5000.00 |
| Total Unusual Items Excluding Goodwill | 0.06 Cr | -0.07 Cr | -0.02 Cr | -5000.00 |
| Net Income From Continuing Operation Net Minority Interest | 1.58 Cr | 0.59 Cr | 0.38 Cr | 0.15 Cr |
| Reconciled Depreciation | 1.81 Cr | 1.91 Cr | 0.28 Cr | 0.12 Cr |
| Reconciled Cost Of Revenue | 49.78 Cr | 24.10 Cr | 20.97 Cr | 4.27 Cr |
| EBITDA | 4.94 Cr | 3.78 Cr | 1.04 Cr | 0.45 Cr |
| EBIT | 3.13 Cr | 1.87 Cr | 0.76 Cr | 0.34 Cr |
| Net Interest Income | -0.67 Cr | -0.79 Cr | -0.48 Cr | -0.18 Cr |
| Interest Expense | 0.63 Cr | 0.76 Cr | 0.48 Cr | 0.17 Cr |
| Interest Income | 4000.00 | 68000.00 | 0.01 Cr | 0.00 |
| Normalized Income | 1.53 Cr | 0.64 Cr | 0.39 Cr | 0.15 Cr |
| Net Income From Continuing And Discontinued Operation | 1.58 Cr | 0.59 Cr | 0.38 Cr | 0.15 Cr |
| Total Expenses | 59.55 Cr | 33.41 Cr | 26.03 Cr | 5.72 Cr |
| Rent Expense Supplemental | 0.25 Cr | 0.26 Cr | 0.28 Cr | 0.10 Cr |
| Diluted NI Availto Com Stockholders | 1.58 Cr | 0.59 Cr | 0.38 Cr | 0.15 Cr |
| Net Income Common Stockholders | 1.58 Cr | 0.59 Cr | 0.38 Cr | 0.15 Cr |
| Otherunder Preferred Stock Dividend | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | 1.58 Cr | 0.59 Cr | 0.38 Cr | 0.15 Cr |
| Minority Interests | -0.36 Cr | -0.22 Cr | 0.02 Cr | 2000.00 |
| Net Income Including Noncontrolling Interests | 1.95 Cr | 0.81 Cr | 0.36 Cr | 0.15 Cr |
| Net Income Continuous Operations | 1.95 Cr | 0.81 Cr | 0.36 Cr | 0.15 Cr |
| Tax Provision | 0.55 Cr | 0.30 Cr | -0.08 Cr | 0.01 Cr |
| Pretax Income | 2.49 Cr | 1.11 Cr | 0.27 Cr | 0.16 Cr |
| Other Non Operating Income Expenses | 0.12 Cr | 0.26 Cr | 0.04 Cr | 44000.00 |
| Special Income Charges | 0.01 Cr | -0.07 Cr | -0.02 Cr | -5000.00 |
| Other Special Charges | -0.01 Cr | 0.02 Cr | 0.02 Cr | — |
| Write Off | 0.00 | 0.06 Cr | 0.16 Cr | 5000.00 |
| Net Non Operating Interest Income Expense | -0.67 Cr | -0.79 Cr | -0.48 Cr | -0.18 Cr |
| Total Other Finance Cost | 0.04 Cr | 0.04 Cr | 0.04 Cr | 59000.00 |
| Interest Expense Non Operating | 0.63 Cr | 0.76 Cr | 0.48 Cr | 0.17 Cr |
| Interest Income Non Operating | 4000.00 | 68000.00 | 0.01 Cr | 0.00 |
| Operating Income | 2.97 Cr | 1.73 Cr | 0.73 Cr | 0.35 Cr |
| Operating Expense | 9.77 Cr | 9.32 Cr | 5.05 Cr | 1.45 Cr |
| Other Operating Expenses | 1.57 Cr | 1.51 Cr | 1.90 Cr | 0.15 Cr |
| Depreciation And Amortization In Income Statement | 1.81 Cr | 1.91 Cr | 0.28 Cr | 0.12 Cr |
| Depreciation Income Statement | 1.81 Cr | 1.91 Cr | 0.28 Cr | 0.12 Cr |
| Selling General And Administration | 2.18 Cr | 1.55 Cr | 0.69 Cr | 0.28 Cr |
| Selling And Marketing Expense | 1.35 Cr | 1.13 Cr | 0.47 Cr | 0.24 Cr |
| General And Administrative Expense | 0.83 Cr | 0.41 Cr | 0.22 Cr | 0.04 Cr |
| Rent And Landing Fees | 0.25 Cr | 0.26 Cr | 0.28 Cr | 0.10 Cr |
| Gross Profit | 12.74 Cr | 11.05 Cr | 5.78 Cr | 1.79 Cr |
| Cost Of Revenue | 49.78 Cr | 24.10 Cr | 20.97 Cr | 4.27 Cr |
| Total Revenue | 62.52 Cr | 35.14 Cr | 26.76 Cr | 6.07 Cr |
| Operating Revenue | 62.52 Cr | 35.14 Cr | 26.76 Cr | 6.07 Cr |
| Diluted Average Shares | — | 0.84 Cr | 0.91 Cr | 0.91 Cr |
| Basic Average Shares | — | 0.84 Cr | 0.91 Cr | 0.91 Cr |
| Diluted EPS | — | 0.70 | 0.42 | 0.17 |
| Basic EPS | — | 0.70 | 0.42 | 0.17 |
| Net Income Discontinuous Operations | — | 0.00 | 0.00 | — |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on WALPAR NUTRITIONS
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.